Rezolve AI is sliding into its June 26 earnings date with a borrow market that has repriced dramatically, a stock down 18% on the week, and an insider base that bought aggressively at higher levels — making the setup arguably more interesting now than it was a few days ago.
The borrow story remains the dominant thread, and it has intensified further since earlier this week. Cost to borrow closed June 9 at 36.3% — up from 30.6% just the day before and roughly five times the ~7% level seen at the end of April. That is not a subtle drift; it reflects genuine competition for a scarce lending pool. Availability sits at roughly 5% of shares lendable — meaning for every twenty shares already borrowed, only one remains available. That reading briefly touched 0.3% on June 3, when the pool was effectively exhausted. The slight easing since then has come alongside a sharp move higher in cost, which is consistent with new supply entering at a premium rather than genuine relaxation of demand. The ORTEX short score climbed to 79.8 on June 9, its highest reading in the tracked window, and ranks in just the second percentile of its universe — a signal that this borrow setup is among the most stressed in the market.
Short interest itself has grinded higher without a single sharp jump. The position now stands at 15.8% of free float — roughly 47.6 million shares — up 3.2% on the week and about 9% over the past month. Days-to-cover from the most recent FINRA settlement sits at 3.35. What is notable about the weekly build is that it arrived as the stock fell 18%, meaning short sellers are not yet covering into weakness — they are adding. The put/call ratio, at 0.25, is near its 20-day average and well below last month's high of 0.28. Options traders are not particularly defensive. That divergence — shorts pressing harder while the options market stays calm — is worth watching as the earnings date approaches.
The insider picture adds a contrasting layer. CEO and founder Daniel Wagner spent $3.25 million buying shares at $4.00 on April 2, when the stock was trading well above current levels. Director Stephen Perry added a further $265,000 at $2.78 in mid-May. Net insider buying over the past 90 days totals roughly $3.5 million across 908,000 shares. That is a meaningful commitment from executives who are underwater on recent purchases, at least at current prices. Institutional ownership shows BlackRock added 2.04 million shares as of May 31, and State Street and Geode both added in the April reporting period — but the holder count of 93 institutions is thin for a Nasdaq-listed name, leaving the stock more exposed to momentum swings than a deeper-owned stock would be.
The fundamental picture is not flattering. The EV/EBITDA multiple is deeply negative, reflecting a company that has not yet reached profitability. The ORTEX growth score sits at a standout 91.2, reflecting strong forward revenue expectations — but the quality score of 21.8 and an ROA of roughly -620% tell the story of a business burning cash to fund that growth. Peers are faring similarly: ARQQ fell 23% on the week, SOUN dropped 20%, and HOLO was off 17% — suggesting this is partly a sector-wide unwind rather than an RZLV-specific event.
The June 26 earnings print is the next hard stop. Prior event history shows RZLV has moved in both directions — down 12% in one session and up 7% in another — so the range of outcomes is wide. With borrow costs at multi-month highs, availability still very tight, and short interest continuing to build, the dynamics heading into that date are worth tracking closely.
See the live data behind this article on ORTEX.
Open RZLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
